Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University, Jinju 52828, Republic of Korea.
Institute of Applied Sciences, HUTECH University, 475A Dien Bien Phu St., Ward 25, Binh Thanh District, Ho Chi Minh City 72300, Vietnam.
J Microbiol Biotechnol. 2023 Aug 28;33(8):1006-1012. doi: 10.4014/jmb.2303.03041. Epub 2023 May 28.
In this study, we investigated the effects of sodium propionate (SP) treatment on intracellular mechanism of murine macrophages and its contribution to host immunity during 544 infection. The intracellular growth assay revealed that SP inhibited replication inside the macrophages. To determine intracellular signaling involved during SP treatment after infection, we analyzed the change of five different cytokines production relevant to SP such as TNF-α, IL-10, IFN-γ, IL-1β, and IL-6, and the results indicated that the boost with IL-10 was apparent throughout the culture period for 48 h as well as IL-1β which was apparent at 24 h post-infection and IFN-γ which was apparent at 24 h and 48 h in comparison to SP untreated groups. On the other way, SP-treated cells displayed suppressed production of TNF-α and IL-6 at all time points tested and 48 h post-infection, respectively. Furthermore, we conducted western blot to establish a cellular mechanism, and the result suggested that SP treatment attenuated p50 phosphorylation, part of the NF-κB pathway. These findings indicated that the inhibitory effect of SP against infection could be attributed through induction of cytokine production and interference on intracellular pathway, suggesting SP as a potential candidate for treating brucellosis.
在这项研究中,我们研究了丙酸钠(SP)处理对 544 感染后鼠巨噬细胞内机制及其对宿主免疫的影响。细胞内生长测定表明 SP 抑制了巨噬细胞内的复制。为了确定感染后 SP 处理过程中的细胞内信号转导,我们分析了与 SP 相关的五种不同细胞因子(TNF-α、IL-10、IFN-γ、IL-1β和 IL-6)产生的变化,结果表明,在整个 48 小时培养期间,IL-10 的增加明显,IL-1β在感染后 24 小时明显,IFN-γ在 24 小时和 48 小时明显,与未用 SP 处理的组相比。另一方面,SP 处理的细胞在所有检测时间点和感染后 48 小时显示 TNF-α和 IL-6 的产生受到抑制。此外,我们进行了 Western blot 以建立细胞机制,结果表明 SP 处理减弱了 NF-κB 途径的 p50 磷酸化。这些发现表明,SP 对感染的抑制作用可能归因于细胞因子的产生诱导和细胞内途径的干扰,表明 SP 可能是治疗布鲁氏菌病的潜在候选药物。